Synergistic Implantable Biotherapeutic Agent Delivery Systems

A novel system integrating nanoporous implantable canisters with AI, IoT, blockchain, and novel materials to enable real-time monitoring, personalized treatment planning, and secure data management for biotherapeutic agent delivery and tissue repair.

The original patent disclosed a metallic, nanoporous device for encapsulating cellular and biotherapeutic agents. However, it lacked the ability to monitor and adjust agent release in real-time, and secure data management. The new inventive concept addresses these limitations by integrating the nanoporous canister with AI-powered biosensors, IoT-enabled sensors, blockchain-based data storage, and novel materials to create a more powerful system.

The synergistic system comprises a nanoporous implantable canister, an AI-powered biosensor for real-time monitoring of agent release and tissue repair, IoT-enabled sensors for monitoring and adjusting canister performance, and a blockchain-based data storage platform for secure and transparent data management. The canister body is made from a novel, biocompatible nanomaterial integrated with a microfluidic channel for controlled agent release. The system enables real-time monitoring, personalized treatment planning, and secure data management, thereby promoting more effective tissue repair.

The new claims introduce the integration of AI, IoT, blockchain, and novel materials with the nanoporous implantable canister, which is not obvious from the original patent. The synergistic combination of these technologies enables real-time monitoring, personalized treatment planning, and secure data management, which is not achievable by the original patent.

Alternative embodiments include using different AI algorithms, IoT sensor configurations, or blockchain platforms. Variations of the system could include integrating with wearable devices, using different nanomaterials, or incorporating additional diagnostic tools.

The synergistic system has significant commercial potential in the fields of regenerative medicine, tissue engineering, and personalized healthcare. The market for biotherapeutic agent delivery systems is growing rapidly, and this inventive concept is poised to capture a significant share by offering a more effective and secure solution.